, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study, GBD 2013 Mortality and Causes of Death Collaborators, vol.385, pp.117-71, 2013.

S. Dalal, J. J. Beunza, J. Volmink, C. Adebamowo, F. Bajunirwe et al., Non-communicable diseases in sub-Saharan Africa: what we know now, Int J Epidemiol, vol.40, pp.885-901, 2011.

G. A. Mensah, G. A. Roth, U. K. Sampson, A. E. Moran, V. L. Feigin et al., GBD 2013 Mortality and Causes of Death collaborators. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study, Cardiovasc J Afr, vol.26, issue.2, pp.6-10, 2013.

K. F. Schulz, Randomized controlled trials, Clin Obstet Gynecol, vol.41, issue.2, pp.245-56, 1998.

M. L. Barreto, Health research in developing countries, BMJ, vol.339, p.4846, 2009.

M. Atani and M. P. Kabore, African Index Medicus: improving access to African health information, S Afr Fam Pract, vol.49, issue.2, pp.4-7, 2007.

J. M. Glanville, C. Lefebvre, J. N. Miles, and J. Camosso-stefinovic, How to identify randomized controlled trials in MEDLINE: ten years on, J Med Libr Assoc, vol.94, pp.130-136, 2006.

E. Pienaar, L. Grobler, K. Busgeeth, A. Eisinga, and N. Siegfried, Developing a geographic search filter to identify randomised controlled trials in Africa: finding the optimal balance between sensitivity and precision, Health Info Libr J, vol.28, pp.210-215, 2011.

, double-blind, placebo-controlled trial, Lancet, vol.385, pp.341-50, 2015.

F. J. Raal, E. A. Stein, R. Dufour, T. Turner, F. Civeira et al., PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial, Lancet, vol.385, pp.331-371, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01830987

J. Raifman, H. E. Lanthorn, S. Rokicki, and G. Fink, The impact of text message reminders on adherence to antimalarial treatment in northern Ghana: a randomized trial, PLoS One, vol.9, p.109032, 2014.

M. X. Rangaka, R. J. Wilkinson, A. Boulle, J. R. Glynn, K. Fielding et al.,

G. Cutsem, Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial, Lancet, vol.384, pp.682-90, 2014.

M. Reck, R. Kaiser, A. Mellemgaard, J. Y. Douillard, S. Orlov et al., Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial, Lancet Oncol, vol.15, pp.143-55, 2014.

Y. Reznik, O. Cohen, R. Aronson, I. Conget, S. Runzis et al., Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial, Lancet, vol.384, pp.1265-72, 2014.

L. Richter, M. J. Rotheram-borus, A. Van-heerden, A. Stein, M. Tomlinson et al., Pregnant women living with HIV (WLH) supported at clinics by peer WLH: a cluster randomized controlled trial, AIDS Behav, vol.18, pp.706-721, 2014.

G. Rosa, F. Majorin, S. Boisson, C. Barstow, M. Johnson et al., Assessing the impact of water filters and improved cook stoves on drinking water quality and household air pollution: a randomised controlled trial in Rwanda, PLoS One, vol.9, p.91011, 2014.

K. N. Ryan, K. B. Stephenson, I. Trehan, R. J. Shulman, C. Thakwalakwa et al., Zinc or albendazole attenuates the progression of environmental enteropathy: a randomized controlled trial, Clin Gastroenterol Hepatol, vol.12, issue.9, 2014.

S. Shekalaghe, M. Rutaihwa, P. F. Billingsley, M. Chemba, C. A. Daubenberger et al., Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, Am J Trop Med Hyg, vol.91, pp.471-80, 2014.

B. Sjouke, G. Langslet, R. Ceska, S. J. Nicholls, S. E. Nissen et al., Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study, Lancet Diabetes Endocrinol, vol.2, pp.455-63, 2014.

D. C. Sokal, P. S. Li, R. Zulu, Q. D. Awori, S. L. Combes et al., Randomized controlled trial of the shang ring versus conventional surgical techniques for adult male circumcision: safety and acceptability, J Acquir Immune Defic Syndr, vol.65, pp.447-55, 2014.

G. Sossauer, M. Zbinden, P. M. Tebeu, G. K. Fosso, S. Untiet et al., Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon, PLoS One, vol.9, p.109788, 2014.

B. Speich, S. M. Ame, S. M. Ali, R. Alles, J. Huwyler et al., Oxantel pamoate-albendazole for Trichuris trichiura infection, N Engl J Med, vol.370, pp.610-630, 2014.

S. A. Sumner, A. J. Pallangyo, E. A. Reddy, V. Maro, B. W. Pence et al., Effect of free distribution of safety equipment on usage among motorcycle-taxi drivers in Tanzaniada cluster randomised controlled trial, Injury, vol.45, pp.1681-1687, 2014.

J. S. Sundy, H. R. Schumache, A. Kivitz, S. P. Weinstein, R. Wu et al., Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study, J Rheumatol, vol.41, pp.1703-1714, 2014.

T. D. Thacher, P. R. Fischer, and J. M. Pettifor, Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial, Arch Dis Child, vol.99, pp.807-818, 2014.

C. Thakwalakwa, A. Phiri, N. Rollins, G. T. Heikens, E. K. Barnell et al., Growth and HIV-free survival of HIV-exposed infants in Malawi: a randomized trial of two complementary feeding interventions in the context of maternal antiretroviral therapy, J Acquir Immune Defic Syndr, vol.66, pp.181-188, 2014.

H. Tinto, S. Diallo, I. Zongo, I. Guiraud, I. Valea et al., Effectiveness of artesunate-amodiaquine vs. artemetherlumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial, Trop Med Int Health, vol.19, pp.469-75, 2014.

A. B. Tiono, D. T. Kangoye, A. M. Rehman, D. G. Kargougou, Y. Kabor-e et al., Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods, PLoS One, vol.9, p.86936, 2014.

W. A. Tol, I. H. Komproe, M. J. Jordans, A. Ndayisaba, P. Ntamutumba et al., School-based mental health intervention for children in war-affected Burundi: a cluster randomized trial, BMC Med, vol.12, p.56, 2014.

M. Tomlinson, T. Doherty, P. Ijumba, D. Jackson, J. Lawn et al., Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township, Trop Med Int Health, vol.19, pp.256-66, 2014.

E. O. Ugwu, S. N. Obi, E. S. Iferikigwe, C. C. Dim, and F. O. Ezugwu, Membrane stripping to prevent post-term pregnancy in Enugu, Nigeria: a randomized controlled trial, Arch Gynecol Obstet, vol.289, issue.1, pp.29-34, 2014.

P. A. West, N. Protopopoff, A. Wright, Z. Kivaju, R. Tigererwa et al., Indoor residual spraying in combination with insecticide-treated nets compared to insecticide-treated nets alone for protection against malaria: a cluster randomised trial in Tanzania, PLoS Med, vol.11, issue.4, p.1001630, 2014.

E. H. Westen, P. R. Kolk, C. L. Van-velzen, R. Unkels, N. S. Mmuni et al., Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial, Acta Obstet Gynecol Scand, vol.94, issue.1, pp.43-52, 2015.

H. Yan, A. Prista, S. M. Ranadive, A. Damasceno, P. Caupers et al., Effect of aerobic training on glucose control and blood pressure in T2DDM East African males, ISRN Endocrinol, p.864897, 2014.

A. Yeka, V. Lameyre, K. Afizi, M. Fredrick, R. Lukwago et al., Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children, PLoS One, vol.9, p.113311, 2014.

L. A. Diakou, Journal of Clinical Epidemiology, vol.82, pp.29-36, 2017.

M. Naghavi, H. Wang, and R. Lozano, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.385, issue.9963, pp.117-71, 2013.

G. A. Mensah, G. A. Roth, U. K. Sampson, A. E. Moran, V. L. Feigin et al., Mortality and Causes of Death collaborators. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study, Cardiovasc J Afr, vol.26, issue.2, pp.6-10, 2013.

P. M. Rothwell, External validity of randomised controlled trials: "to whom do the results of this trial apply?, Lancet, vol.365, issue.9453, pp.82-93, 2005.

H. E. Burchett, M. J. Dobrow, J. N. Lavis, and S. H. Mayhew, The applicability and transferability of public health research from one setting to another: a survey of maternal health researchers, Glob Health Promot, vol.20, issue.1, pp.16-24, 2013.

P. Garner, R. Kale, R. Dickson, T. Dans, and R. Salinas, Getting research findings into practice: implementing research findings in developing countries, BMJ, vol.317, issue.7157, pp.531-536, 1998.

X. Anglaret, C. A. Scott, R. P. Walensky, E. Ouattara, E. Losina et al., Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis, Antivir Ther, vol.18, issue.1, pp.45-55, 2012.

C. Seyler, C. Adjé-touré, E. Messou, N. Dakoury-dogbo, F. Rouet et al., Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa, AIDS, vol.21, issue.9, pp.1157-64, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00172158

I. Chalmers and P. Glasziou, Avoidable waste in the production and reporting of research evidence, Lancet, vol.374, issue.9683, pp.60329-60338, 2009.

Y. Yordanov, A. Dechartres, R. Porcher, I. Boutron, D. G. Altman et al., Avoidable waste of research related to inadequate methods in clinical trials, BMJ, vol.350, p.809, 2015.

P. Glasziou, E. Meats, C. Heneghan, and S. Shepperd, What is missing from descriptions of treatment in trials and reviews?, BMJ, vol.336, issue.7659, pp.1472-1476, 2008.

P. Glasziou, D. G. Altman, P. Bossuyt, I. Boutron, M. Clarke et al., Reducing waste from incomplete or unusable reports of biomedical research, Lancet, vol.383, issue.9913, pp.267-76, 2014.

N. Diakou, L. A. , F. Ntoumi, P. Ravaud, and I. Boutron, Published randomized trials performed in Sub-Saharan Africa focus on high burden diseases but are frequently funded and led by high income countries, J Clin Epidemiol, 2016.

D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and . Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, vol.6, issue.7, p.1000097, 2009.

J. M. Glanville, C. Lefebvre, J. N. Miles, and J. Camosso-stefinovic, How to identify randomized controlled trials in MEDLINE: ten years on, J Med Libr Assoc, vol.94, issue.2, pp.130-136, 2006.

E. Pienaar, L. Grobler, K. Busgeeth, A. Eisinga, and N. Siegfried, Developing a geographic search filter to identify randomized controlled trials in Africa: finding the optimal balance between sensitivity and precision, Health Info Libr J, vol.28, issue.3, pp.210-215, 2011.

M. Atani and M. P. Kabore, African Index Medicus: improving access to African health information, SA Fam Pract, vol.49, issue.2, pp.4-7, 2007.

J. P. Higgins, D. G. Altman, P. C. Gøtzsche, P. Jüni, D. Moher et al., Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials, BMJ, vol.343, p.5928, 2011.

J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version, 2008.

D. Moher, S. Hopewell, K. F. Schulz, V. Montori, P. C. Gøtzsche et al., explanation and elaboration: updated guidelines for reporting parallel group randomised trials, BMJ, vol.340, p.869, 2010.

I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud et al., Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration, Ann Intern Med, vol.148, issue.4, pp.295-309, 2008.

T. C. Hoffmann, P. P. Glasziou, I. Boutron, R. Milne, R. Perera et al., Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide, BMJ, vol.348, p.1687, 2014.

P. Craig, P. Dieppe, S. Macintyre, S. Michie, I. Nazareth et al., Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance, BMJ, vol.337, p.1655, 2008.

P. Isaakidis and J. Ioannidis, Evaluation of cluster randomized controlled trials in Sub-Saharan Africa, Am J Epidemiol, vol.158, pp.921-927, 2003.

N. Siegfried, M. Clarke, J. Volmink, and L. Van-der-merwe, African HIV/AIDS trials are more likely to report adequate allocation concealment and random generation than North American trials, PLoS One, vol.3, issue.10, p.3491, 2008.

B. Zani, E. D. Pienaar, J. Oliver, and N. Siegfried, Randomized controlled trials of HIV/ AIDS prevention and treatment in Africa: results from the Cochrane HIV/ AIDS Specialized Register, PLoS One, vol.6, issue.12, p.28759, 2011.

V. Lutje, A. Gerritsen, and N. Siegfried, Randomized controlled trials of malaria intervention trials in Africa, 1948 to 2007: a descriptive analysis, Malar J, vol.10, p.61, 2011.

S. Hopewell, S. Dutton, L. M. Yu, A. W. Chan, and D. G. Altman, The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed, BMJ, vol.340, p.723, 2010.

A. Dechartres, P. Charles, S. Hopewell, P. Ravaud, and D. G. Altman, Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed, J Clin Epidemiol, vol.64, issue.2, pp.136-180, 2011.

T. C. Hoffmann, C. Erueti, and P. P. Glasziou, Poor description of nonpharmacological interventions: analysis of consecutive sample of randomized trials, BMJ, vol.347, p.3755, 2013.

S. Schroter, P. Glasziou, and C. Heneghan, Quality of descriptions of treatments: a review of published randomised controlled trials, BMJ Open, vol.2, p.6, 2012.

A. C. Plint, D. Moher, A. Morrison, K. Schulz, D. G. Altman et al., Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review, Med J Aust, vol.185, issue.5, pp.263-270, 2006.

L. Turner, L. Shamseer, D. G. Altman, L. Weeks, J. Peters et al., Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals, Cochrane Database Syst Rev, vol.11, p.30, 2012.

M. J. To, J. Jones, M. Emara, and A. R. Jadad, Are reports of randomized controlled trials improving over time? A systematic review of 284 articles published in high-impact general and specialized medical journals, PLoS One, vol.8, issue.12, p.84779, 2013.

S. Hopewell, D. G. Altman, D. Moher, and K. F. Schulz, Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal "Instructions to Authors, Trials, vol.9, p.20, 2008.

T. Hoffmann, T. English, and P. Glasziou, Reporting of interventions in randomised trials: an audit of journal instructions to authors, Trials, vol.15, p.20, 2014.

M. Nagendran, D. Harding, W. Teo, C. Camm, M. Maruthappu et al., Poor adherence of randomised trials in surgery to CONSORT guidelines for non-pharmacological treatments (NPT): a cross-sectional study, BMJ Open, vol.3, issue.12, p.3898, 2013.

C. Barnes, I. Boutron, B. Giraudeau, R. Porcher, D. G. Altman et al., Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial, BMC Med, vol.13, p.221, 2015.

N. Ahmad, I. Boutron, A. Dechartres, P. Durieux, and P. Ravaud, Geographical representativeness of published and ongoing randomized controlled trials

C. J. Murray, T. Vos, and R. Lozano, Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.380, issue.9859, pp.61689-61693, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00827610

T. Vos, C. Allen, and M. Arora, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study, The Lancet, vol.388, pp.1545-1602, 2015.

J. M. Kirigia, M. O. Ota, F. Senkubuge, C. S. Wiysonge, and B. M. Mayosi, Developing the African national health research systems barometer. Health Research Policy and Systems, vol.14, 2016.

E. F. Adebayo, O. A. Uthman, C. S. Wiysonge, E. A. Stern, K. T. Lamont et al., A systematic review of factors that affect uptake of community-based health insurance in low-income and middleincome countries, BMC Health Services Research, vol.15, issue.1, 2015.

O. Cenciarelli, S. Pietropaoli, and A. Malizia, Ebola Virus Disease 2013-2014 Outbreak in West Africa: An Analysis of the Epidemic Spread and Response, International Journal of Microbiology, vol.2015, pp.1-12, 2015.

C. Murray, R. M. Barber, and K. J. Foreman, Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. The Lancet, vol.386, pp.2145-2191, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01262808

M. Chopra and E. Mason, Millennium Development Goals: background. Archives of Disease in Childhood, vol.100, 2015.

J. D. Sachs, From Millennium Development Goals to Sustainable Development Goals, The Lancet

, , vol.379, pp.2206-2211

, World Health Organization. World health statistics 2017: monitoring health for the SDGs, Sustainable Development Goals, 2017.

L. Alkema, D. Chou, and D. Hogan, Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group, Lancet, vol.387, pp.462-474, 2016.

C. Lachat, D. Roberfroid, and L. Van-den-broeck, A decade of nutrition research in Africa: assessment of the evidence base and academic collaboration, Public Health Nutrition, vol.18, issue.10, pp.1890-1897, 2015.

B. J. Akombi, K. E. Agho, D. Merom, A. M. Renzaho, and J. J. Hall, Child malnutrition in sub-Saharan Africa: A meta-analysis of demographic and health surveys, World Health Organization. World Malaria Report, vol.12, issue.5, p.177338, 2006.

P. W. Gething, D. C. Casey, and D. J. Weiss, Mapping Plasmodium falciparum Mortality in Africa between 1990 and 2015. The New England journal of medicine, vol.375, pp.2435-2445, 2016.

W. P. O'meara, J. N. Mangeni, R. Steketee, and B. Greenwood, Changes in the burden of malaria in sub

S. Africa, The Lancet Infectious diseases, vol.10, pp.70096-70103, 2010.

C. Lengeler, Insecticide-treated bed nets and curtains for preventing malaria. The Cochrane database of systematic reviews, p.363, 2004.

S. Bhatt, D. J. Weiss, and B. Mappin, Coverage and system efficiencies of insecticide-treated nets in Africa from, eLife, vol.4, 2000.

M. Theisen, B. Adu, B. Mordmüller, and S. Singh, The GMZ2 malaria vaccine: from concept to efficacy in humans. Expert Review of Vaccines, pp.1-11, 2017.

S. Mahmoudi, H. Keshavarz, and . Sida, Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan. Human Vaccines & Immunotherapeutics, pp.1-4, 2015.

H. F. Gunthard, M. S. Saag, and C. A. Benson, Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel, Jama, vol.316, issue.2, pp.191-210, 2016.

A. R. Omran, The epidemiologic transition. A theory of the Epidemiology of population change, Bulletin of the World Health Organization, vol.79, issue.2, pp.161-170, 1971.

G. A. Atiim and S. J. Elliott, The Global Epidemiologic Transition: Noncommunicable Diseases and Emerging Health Risk of Allergic Disease in Sub-Saharan Africa. Health Education & Behavior, vol.43, pp.37-55, 2016.

B. K. Defo, Demographic, epidemiological, and health transitions: are they relevant to population health patterns in Africa?, Rasmussen C, Nyunt MM, Ringwald P. Artemisinin-Resistant Plasmodium falciparum in Africa, vol.7, p.22443, 2014.

, N Engl J Med, vol.377, issue.3, pp.305-306, 2017.

D. A. Karagiannis-voules, P. Biedermann, and U. F. Ekpo, Spatial and temporal distribution of soiltransmitted helminth infection in sub-Saharan Africa: a systematic review and geostatistical meta-analysis. The Lancet Infectious diseases, vol.15, pp.74-84, 2015.

A. B. Sudeep and D. Parashar, Chikungunya: an overview, Journal of biosciences, vol.33, issue.4, pp.443-449, 2008.

G. Grard, M. Caron, and I. M. Mombo, Zika Virus in Gabon (Central Africa) -2007: A New Threat from Aedes albopictus? Charrel R, vol.8, p.2681, 2014.

L. Allen, Are we facing a noncommunicable disease pandemic? Journal of epidemiology and global health, vol.7, pp.5-9, 2017.

P. Farmer, J. Frenk, and F. M. Knaul, Expansion of cancer care and control in countries of low and middle income: a call to action, Lancet, vol.376, issue.9747, p.61152, 2010.

S. Dalal, J. J. Beunza, and J. Volmink, Non-communicable diseases in sub-Saharan Africa: what we know now, International Journal of Epidemiology, vol.40, issue.4, pp.3536-3540, 2005.

G. A. Mensah, Ischaemic heart disease in Africa. Heart (British Cardiac Society), vol.94, pp.836-843, 2008.

C. L. Onen, Epidemiology of ischaemic heart disease in sub-Saharan Africa, Cardiovascular journal of Africa, vol.24, issue.2, pp.34-42, 2013.

F. Ataklte, S. Erqou, S. Kaptoge, B. Taye, J. B. Echouffo-tcheugui et al., Burden of Undiagnosed Hypertension in Sub-Saharan Africa: A Systematic Review and Meta-Analysis, Hypertension, vol.65, issue.2, pp.291-298, 2015.

M. M. Ibrahim and A. Damasceno, Hypertension in developing countries, Lancet

, , vol.380, pp.60861-60868

M. D. Connor, R. Walker, G. Modi, and C. P. Warlow, Burden of stroke in black populations in sub-Saharan Africa. The Lancet Neurology, vol.6, pp.269-278, 2007.

M. J. O'donnell, D. Xavier, and L. Liu, Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study, Lancet

, , vol.376, pp.60834-60837

J. Mbanya, A. A. Motala, E. Sobngwi, F. K. Assah, and S. T. Enoru, Diabetes in sub-Saharan Africa. The Lancet, vol.375, pp.60550-60558, 2010.

D. M. Parkin, F. Sitas, M. Chirenje, L. Stein, R. Abratt et al., Part I: Cancer in Indigenous Africans--burden, distribution, and trends. The Lancet Oncology, vol.9, p.70175, 2008.

F. Sitas, D. M. Parkin, M. Chirenje, L. Stein, R. Abratt et al., Cancer in Indigenous Africans--causes and control, vol.9, pp.786-795, 2008.

M. Rahman and T. Fukui, Biomedical publication-global profile and trend, Public Health, vol.117, issue.4, pp.274-280, 2003.

D. G. Altman, What randomized trials and systematic reviews can offer decision makers. Hormone research, vol.51, pp.36-43, 1999.

D. L. Sackett, W. M. Rosenberg, J. A. Gray, R. B. Haynes, and W. S. Richardson, Evidence based medicine: what it is and what it isn't. BMJ (Clinical research ed), vol.312, pp.71-72, 1996.

G. Guyatt, EBM has not only called out the problems but offered solutions, Journal of Clinical Epidemiology, vol.84, pp.8-10, 2017.

L. Salvador-carulla, S. Lukersmith, and W. Sullivan, From the EBM pyramid to the Greek temple: a new conceptual approach to Guidelines as implementation tools in mental health, Epidemiology and Psychiatric Sciences, vol.26, issue.02, pp.105-114, 2017.

D. W. Fraser, Overlooked opportunities for investing in health research and development, Bulletin of the World Health Organization, vol.78, issue.8, pp.1054-1061, 2000.

C. Perez, S. Folkesson, E. Anglaret, and X. , Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa. Schibler M, vol.11, p.5545, 2017.

P. M. Rothwell, Factors That Can Affect the External Validity of Randomised Controlled Trials, PLoS Clinical Trials, vol.1, issue.1, p.9, 2006.

O. M. Dekkers, E. Von-elm, A. Algra, J. A. Romijn, and J. P. Vandenbroucke, How to assess the external validity of therapeutic trials: a conceptual approach, International journal of epidemiology, vol.39, issue.1, pp.89-94, 2010.

N. Ahmad, I. Boutron, A. Dechartres, P. Durieux, and P. Ravaud, Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review, Trials, vol.11, issue.1, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00663771

A. L. Schwartz and A. B. Friedman, Geographic Variations in Controlled Trials, N Engl J Med, vol.376, issue.12, p.1196, 2017.

M. A. Casale, S. Flicker, S. Nixon, R. Arvanitis, J. Waast et al., Fieldwork challenges: lessons learned from a north-south public health research partnership. Health promotion practice, Scientometrics, vol.12, issue.5, pp.229-241, 2002.

N. Siegfried, Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution, BMJ, vol.331, issue.7519, 2005.

M. I. Matee, C. Manyando, and P. M. Ndumbe, European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership, BMC public health, vol.9, p.249, 2009.

S. H. Mayhew, J. Doherty, and S. Pitayarangsarit, Developing health systems research capacities through north-south partnership: an evaluation of collaboration with South Africa and Thailand. Health research policy and systems, vol.6, 2008.

A. Costello and A. Zumla, Moving to research partnerships in developing countries, Clinical research ed), vol.321, issue.7264, pp.827-829, 2000.

A. Zumla, J. Huggett, K. Dheda, C. Green, N. Kapata et al., Trials and tribulations of an African-led research and capacity development programme: the case for EDCTP investments. Tropical medicine & international health, Malaria journal, vol.15, issue.4, p.103, 2010.

G. M. Miiro, O. O. Oukem-boyer, and O. Sarr, EDCTP regional networks of excellence: initial merits for planned clinical trials in Africa, BMC public health, vol.13, p.258, 2013.

G. H. Swingler, V. Pillay, E. D. Pienaar, and J. Ioannidis, International collaboration, funding and association with burden of disease in randomized controlled trials in Africa, Bull World Health Organ, vol.83, issue.7, pp.511-517, 2005.

S. Gottlieb, Companies reduce prices for HIV drugs in developing countries, Bull World Health Organ, vol.78, issue.6, p.862, 2000.

G. J. Annas, Globalized Clinical Trials and Informed Consent, New England Journal of Medicine, vol.360, issue.20, pp.2050-2053, 2009.

J. Lenzer, Pfizer settles with victims of Nigerian drug trial, BMJ, vol.343, pp.5268-5268, 2011.

M. Vray, F. Simon, and F. Bompart, Guidelines for Clinical Research in Developing Countries, Thérapie, vol.62, issue.3, pp.223-227, 2007.

X. Anglaret and P. Msellati, Éthique contextuelle ou éthique universelle: un faux débat ? Réflexions issues de la pratique d'essais cliniques en Côte d'Ivoire, AUTREPART, issue.28, pp.71-80, 2003.

N. Vischer, C. Pfeiffer, M. Limacher, and C. Burri, You can save time if?, A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa. Diemert DJ, vol.12, p.173796, 2017.

R. Ravinetto, A. Buve, and T. Halidou, Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? Tropical medicine & international health, TM & IH, vol.16, issue.4, pp.527-530, 2011.

G. S. The, Declaration of Helsinki: some reflections, Journal of medical ethics, vol.36, issue.10, pp.598-603, 2008.

E. D. Pienaar, The availability of health information in South Africa, Medinfo, vol.8, 1995.

A. L. Abrams, One of a kind--the Pan African Clinical Trials Registry, a regional registry for Africa. The Pan African medical journal, vol.9, p.42, 2011.

G. Winkmann, S. Schlutius, and H. Schweim, Publikationssprachen der Impact Faktor-Zeitschriften und medizinischer Literaturdatenbanken. DMW -Deutsche Medizinische Wochenschrift, vol.127, pp.131-137, 2002.

P. A. Singer, Recent advances. Medical ethics, BMJ, vol.321, issue.7256, pp.282-285, 2000.

R. Horton, North and South: bridging the information gap, The Lancet, vol.355, issue.9222, pp.2231-2236, 2000.

M. Atani and M. P. Kabore, African Index Medicus: improving access to African health information, vol.49, pp.4-7, 2007.

I. Bertrand and L. Hunter, African Index Medicus--a cooperative undertaking, Health Libr Rev, vol.15, issue.1, pp.17-20, 1998.

D. G. Altman, The scandal of poor medical research, BMJ, vol.308, issue.6924, pp.283-284, 1994.

I. Chalmers and P. Glasziou, Avoidable waste in the production and reporting of research evidence, The Lancet, vol.374, issue.9683, pp.60329-60338, 2009.

S. Kleinert and R. Horton, How should medical science change? The Lancet, vol.383, pp.197-198, 2014.

I. Chalmers, M. B. Bracken, and B. Djulbegovic, How to increase value and reduce waste when research priorities are set. The Lancet, vol.383, pp.62229-62230, 2014.

J. Ioannidis, S. Greenland, and M. A. Hlatky, Increasing value and reducing waste in research design, conduct, and analysis. The Lancet, vol.383, pp.62227-62235, 2014.

R. Salman, E. Beller, and J. Kagan, Increasing value and reducing waste in biomedical research regulation and management. The Lancet, vol.383, pp.62297-62304, 2014.

A. Chan, F. Song, and A. Vickers, Increasing value and reducing waste: addressing inaccessible research, The Lancet, vol.383, issue.9913, pp.62296-62301, 2014.

P. Glasziou, D. G. Altman, and P. Bossuyt, Reducing waste from incomplete or unusable reports of biomedical research, The Lancet, vol.383, issue.9913, pp.267-276, 2014.

D. Moher, P. Glasziou, and I. Chalmers, Increasing value and reducing waste in biomedical research: who's listening? The Lancet, vol.387, pp.1573-1586, 2016.

F. S. Collins and . Basics, Science, vol.337, issue.6094, pp.503-503, 2012.

D. G. Contopoulos-ioannidis, G. A. Alexiou, T. C. Gouvias, and J. Ioannidis, Life Cycle of Translational Research for Medical Interventions, Science, vol.321, issue.5894, pp.1298-1299, 2008.

I. Chalmers, Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, BMJ, vol.327, issue.7422, 1980.

J. Ioannidis, More time for research: Fund people not projects, Nature, vol.477, issue.7366, pp.529-531, 2011.

L. A. Gillum, C. Gouveia, and E. R. Dorsey, NIH Disease Funding Levels and Burden of Disease

J. Ross and E. , PLoS ONE, vol.6, issue.2, p.16837, 2011.

S. M. Chang, T. S. Carey, E. U. Kato, J. Guise, and G. D. Sanders, Identifying research needs for improving health care, Ann Intern Med, vol.157, issue.6, pp.439-445, 2012.

M. Nasser, V. Welch, P. Tugwell, E. Ueffing, J. Doyle et al., Ensuring relevance for Cochrane reviews: evaluating processes and methods for prioritizing topics for Cochrane reviews, Journal of Clinical Epidemiology, vol.66, issue.5, pp.474-482, 2013.

A. P. Jones, E. Conroy, P. R. Williamson, M. Clarke, and C. Gamble, The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials, BMC Medical Research Methodology, vol.13, issue.1, 2013.

K. A. Robinson and S. N. Goodman, A Systematic Examination of the Citation of Prior Research in Reports of Randomized, Controlled Trials. Annals of Internal Medicine, vol.154, issue.1, p.50, 2011.

D. G. Altman, Poor-quality medical research: what can journals do?, JAMA, vol.287, issue.21, pp.2765-2767, 2002.

J. Ioannidis and M. J. Khoury, Improving Validation Practices in, Omics" Research. Science

, , vol.334, pp.1230-1232

T. Hagen and K. G. , Novel or reproducible: That is the question, Glycobiology, vol.26, issue.5, pp.429-429, 2016.

J. Savovi?, H. E. Jones, and D. G. Altman, Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials, Annals of Internal Medicine, vol.157, issue.6, p.429, 2012.

A. Hrobjartsson, A. S. Thomsen, and F. Emanuelsson, Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors, Clinical research ed), vol.344, p.1119, 2012.

A. Hrobjartsson, A. S. Thomsen, and F. Emanuelsson, Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol.185, issue.4, pp.201-212, 2013.

E. A. Akl, M. Briel, and J. J. You, Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review, Clinical research ed), vol.344, p.2809, 2012.

A. P. Verhagen, H. C. De-vet, R. A. De-bie, M. Boers, and P. A. Van-den-brandt, The art of quality assessment of RCTs included in systematic reviews, Journal of clinical epidemiology, vol.54, issue.7, pp.651-654, 2001.

I. Boutron and P. Ravaud, Classification systems to improve assessment of risk of bias, Journal of clinical epidemiology, vol.65, issue.3, pp.236-238, 2012.

J. Higgins, D. G. Altman, and P. C. Gotzsche, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, vol.343, issue.2, pp.5928-5928, 2008.

Y. Yordanov, A. Dechartres, R. Porcher, I. Boutron, D. G. Altman et al., Avoidable waste of research related to inadequate methods in clinical trials, BMJ, vol.350, pp.809-809, 2015.

A. Dechartres, L. Trinquart, and I. Atal, Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study, BMJ, p.2490, 2017.

S. Shaw, Research governance: regulating risk and reducing harm, Journal of the Royal Society of Medicine, vol.99, issue.1, pp.14-19, 2006.

A. Slowther, Research governance: ethical issues, Journal of the Royal Society of Medicine, vol.99, issue.2, pp.65-72, 2006.

P. Ndebele, C. Blanchard-horan, A. Shahkolahi, and I. Sanne, Regulatory Challenges Associated With Conducting Multicountry Clinical Trials in Resource-Limited Settings, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.65, pp.29-31, 2014.

S. R. Tunis, D. B. Stryer, and C. M. Clancy, Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy, JAMA, vol.290, issue.12, pp.1624-1632, 2003.

A. A. Alsheikh-ali, W. Qureshi, M. H. Al-mallah, and J. Ioannidis, Public Availability of Published Research Data in High-Impact Journals. Boutron I, vol.6, p.24357, 2011.

G. H. Guyatt, A. D. Oxman, and V. Montori, GRADE guidelines: 5. Rating the quality of evidence-publication bias, Journal of Clinical Epidemiology, vol.64, issue.12, pp.1277-1282, 2011.

A. Hrobjartsson, Why did it take 19 months to retrieve clinical trial data from a non-profit organisation?, BMJ, vol.347, pp.6927-6927, 2013.

F. Song, A. J. Eastwood, S. Gilbody, L. Duley, and A. J. Sutton, Publication and related biases, Health Technol Assess, vol.4, issue.10, pp.1-115, 2000.

M. K. Sinha and V. M. Montori, Reporting bias and other biases affecting systematic reviews and metaanalyses: a methodological commentary, Expert Review of Pharmacoeconomics & Outcomes Research, vol.6, issue.5, pp.603-611, 2006.

S. Hopewell, K. Loudon, M. J. Clarke, A. D. Oxman, and K. Dickersin, Publication bias in clinical trials due to statistical significance or direction of trial results, The Cochrane Collaboration, 2009.

K. Dickersin, Y. I. Min, and C. L. Meinert, Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards, JAMA, vol.267, issue.3, pp.374-378, 1992.

S. Hopewell, M. Clarke, L. Stewart, and J. Tierney, Time to publication for results of clinical trials

, Cochrane Database Syst Rev, issue.2, p.11, 2007.

F. Song, S. Parekh, and L. Hooper, Publication bias: evidence of delayed publication in a cohort study of clinical research projects, Stern JM, Simes RJ, vol.315, pp.640-645, 1997.

P. Saini, Y. K. Loke, C. Gamble, D. G. Altman, P. R. Williamson et al., Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews, BMJ, vol.349, issue.3, pp.6501-6501, 2014.

K. Dwan, D. G. Altman, and J. A. Arnaiz, Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias, PLoS ONE, vol.3, issue.8, p.3081, 2008.

A. Chan, A. Pello, and J. Kitchen, Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications, JAMA, 2017.

J. Xia, J. Wright, and C. E. Adams, Five large Chinese biomedical bibliographic databases: accessibility and coverage, Health Information and Libraries Journal, vol.25, issue.1, pp.55-61, 2008.

J. A. Proehl, S. Alexander, and A. Manton, Goldacre B. Make journals report clinical trials properly, Clinical Trials. Journal of Emergency Nursing, vol.43, issue.2, pp.7-7, 2016.

B. Hill and A. , Reasons for writing, BMJ, vol.2, p.870, 1965.

S. N. Goodman, D. Fanelli, and J. Ioannidis, What does research reproducibility mean?, Science Translational Medicine, vol.8, issue.341, pp.341-353, 2016.

P. Austin and M. Robertson, Transparency, reproducibility, credibility: announcing a pilot, BMC Biology, vol.13, issue.1, 2015.

P. Glasziou, E. Meats, C. Heneghan, and S. Shepperd, What is missing from descriptions of treatment in trials and reviews?, BMJ, vol.336, issue.7659, pp.1472-1474, 2008.

T. C. Hoffmann, C. Erueti, and P. P. Glasziou, Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials, BMJ, vol.347, pp.3755-3755, 2013.

I. Simera, D. Moher, A. Hirst, J. Hoey, K. F. Schulz et al., Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network, BMC Medicine, vol.8, issue.1, 2010.

D. Moher, S. Hopewell, and K. F. Schulz, Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials, Journal of clinical epidemiology, vol.63, issue.8, pp.1-37, 2010.

L. Turner, L. Shamseer, D. G. Altman, K. F. Schulz, and D. Moher, Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa, Systematic Reviews, vol.1, issue.1, 2012.

T. C. Hoffmann, P. P. Glasziou, and I. Boutron, Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide, BMJ, vol.348, issue.3, pp.1687-1687, 2014.

E. Cobo, J. Cortes, and J. M. Ribera, Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial, BMJ, vol.343, issue.2, pp.6783-6783, 2011.

S. Kiritchenko, B. De-bruijn, S. Carini, J. Martin, and I. Sim, ExaCT: automatic extraction of clinical trial characteristics from journal publications, BMC Medical Informatics and Decision Making, vol.10, issue.1, 2010.

D. L. Schriger and D. G. Altman, Inadequate post-publication review of medical research, BMJ

, , pp.3803-3803

I. Simera and D. G. Altman, Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines, Evidence-Based Medicine, vol.14, issue.5, pp.132-134, 2009.

D. A. Zarin, T. Tse, R. J. Williams, and S. Carr, Goldacre B. The WHO joint statement from funders on trials transparency, New England Journal of Medicine, vol.375, issue.20, p.2816, 2016.

D. B. Taichman, P. Sahni, and A. Pinborg, Data sharing statements for clinical trials: a requirement of the International Committee of, Medical Journal Editors. Bulletin of the World Health Organization, vol.95, issue.7, pp.482-483, 2017.

P. J. Hotez and A. Kamath, Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden, PLoS neglected tropical diseases, vol.3, issue.8, p.412, 2009.

W. L. Kilama, The 10/90 gap in sub-Saharan Africa: Resolving inequities in health research, Acta Tropica, vol.112, pp.8-15, 2009.

M. E. Kruk, M. Myers, S. T. Varpilah, and B. T. Dahn, What is a resilient health system? Lessons from Ebola. The Lancet, vol.385, pp.60755-60758, 2015.

J. A. Evans, J. Shim, and J. Ioannidis, Attention to Local Health Burden and the Global Disparity of Health, PLoS ONE, vol.9, issue.4, p.90147, 2014.

N. Ahmad, I. Boutron, A. Dechartres, P. Durieux, and P. Ravaud, Geographical Representativeness of Published and Ongoing Randomized Controlled Trials. The Example of: Tobacco Consumption and HIV Infection. Chêne G, PLoS ONE, vol.6, issue.2, p.16878, 2011.

P. M. Rothwell, External validity of randomised controlled trials, The Lancet, vol.365, pp.82-93, 2005.

M. J. Page, J. Higgins, G. Clayton, J. Sterne, A. Hróbjartsson et al., Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies, PLOS ONE, vol.11, issue.7, p.159267, 2016.

K. F. Schulz, Unbiased research and the human spirit: the challenges of randomized controlled trials, CMAJ, vol.153, issue.6, pp.783-786, 1995.

J. M. Glanville, C. Lefebvre, J. Miles, and J. Camosso-stefinovic, How to identify randomized controlled trials in MEDLINE: ten years on, J Med Libr Assoc, vol.94, issue.2, pp.130-136, 2006.

M. A. Kana, Publish or perish" is good for African research, BMJ, p.121, 2016.

P. Isaakidis and J. Ioannidis, Evaluation of cluster randomized controlled trials in sub-Saharan Africa, Am J Epidemiol, vol.158, issue.9, pp.921-926, 2003.

K. M. Chu, S. Jayaraman, P. Kyamanywa, and G. Ntakiyiruta, Building Research Capacity in Africa: Equity and Global Health Collaborations, PLoS Medicine, vol.11, issue.3, p.1001612, 2014.

M. D. Holmes, S. Dalal, and J. Volmink, Non-Communicable Diseases in Sub-Saharan Africa: The Case for Cohort Studies, PLoS Medicine, vol.7, issue.5, p.1000244, 2010.

I. Magrath, Building capacity for cancer control in developing countries: the need for a paradigm shift, The Lancet Oncology, vol.8, issue.7, pp.562-563, 2007.

J. P. Vandenbroucke, Observational Research, Randomised Trials, and Two Views of Medical Science, PLoS Medicine, vol.5, issue.3, p.67, 2008.

I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud et al., Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration, Ann Intern Med, vol.148, issue.4, pp.295-309, 2008.

V. Lutje, A. Gerritsen, and N. Siegfried, Randomized controlled trials of malaria intervention trials in

, a descriptive analysis, Malaria Journal, vol.10, issue.1, p.61, 1948.

S. Schroter, P. Glasziou, C. Heneghan, M. Nagendran, D. Harding et al., Poor adherence of randomised trials in surgery to CONSORT guidelines for non-pharmacological treatments (NPT): a cross-sectional study, BMJ Open, vol.2, issue.6, p.3898, 2012.

T. T. Edejer, North-South research partnerships: the ethics of carrying out research in developing countries, BMJ, vol.319, issue.7207, pp.438-441, 1999.

D. L. Heymann, J. Liu, and L. L. Partnerships, Not Parachutists, for Zika Research. The New England journal of medicine, vol.374, pp.1504-1505, 2016.

P. Isaakidis, G. H. Swingler, E. Pienaar, J. Volmink, J. Ioannidis et al., Mapping of research on maternal health interventions in low-and middle-income countries: a review of 2292 publications between, 702. 170. Falagas ME, vol.324, pp.1199-1205, 2000.

L. Nordling, African nations vow to support science, Nature, vol.465, issue.7301, pp.994-995, 2010.

E. Smith, M. Hunt, and Z. Master, Authorship ethics in global health research partnerships between researchers from low or middle income countries and high income countries, BMC Medical Ethics, vol.15, issue.1, 2014.

W. Kilama, From research to control: Translating research findings into health policies, operational guidelines and health products, Acta Tropica, vol.112, pp.91-101, 2009.

O. A. Uthman, C. S. Wiysonge, and M. O. Ota, Increasing the value of health research in the WHO African Region beyond 2015--reflecting on the past, celebrating the present and building the future: a bibliometric analysis, BMJ Open, vol.5, issue.3, pp.6340-006340, 2015.

K. J. Hofman, C. W. Kanyengo, B. A. Rapp, and S. Kotzin, Mapping the health research landscape in Sub-Saharan Africa: a study of trends in biomedical publications, Journal of the Medical Library Association : JMLA, vol.97, issue.1, pp.41-44, 2009.

K. Klipstein-grobusch, T. Chirwa, and S. Fonn, Current status and future prospects of epidemiology and public health training and research in the WHO African region, International Journal of Epidemiology, vol.42, issue.5, pp.1522-1523, 2013.

J. Ioannidis, Hijacked evidence-based medicine: stay the course and throw the pirates overboard, Journal of Clinical Epidemiology, vol.84, pp.11-13, 2017.

J. Volmink, Addressing inequalities in research capacity in Africa, BMJ, vol.331, issue.7519, pp.705-706, 2005.

F. Binka, Editorial: North-South research collaborations: a move towards a true partnership? Tropical Medicine and International Health, vol.10, pp.207-209, 2005.

K. Ruggeri, Disseminating health research in sub-Saharan Africa through journal partnerships. The Lancet Global Health, vol.2, pp.193-194, 2014.

J. A. Whitworth, G. Kokwaro, and S. Kinyanjui, Strengthening capacity for health research in Africa. The Lancet, vol.372, pp.61660-61668, 2008.

M. Käser, C. Maure, and B. Halpaap, Research Capacity Strengthening in Low and Middle Income Countries -An Evaluation of the WHO/TDR Career Development Fellowship Programme

P. Mwinzi and E. , PLOS Neglected Tropical Diseases, vol.10, issue.5, p.4631, 2016.

N. Siegfried, M. Clarke, J. Volmink, and L. Van-der-merwe, African HIV/AIDS Trials Are More Likely to Report Adequate Allocation Concealment and Random Generation than North American Trials. Evans SR, PLoS ONE, vol.3, issue.10, p.3491, 2008.

R. Yousefi-nooraie and B. Shakiba, Mortaz-Hejri S. Country development and manuscript selection bias: a review of published studies, BMC Medical Research Methodology, vol.6, issue.1, 2006.

G. H. Swingler and M. Zwarenstein, An effectiveness trial of a diagnostic test in a busy outpatients department in a developing country: issues around allocation concealment and envelope randomization, J Clin Epidemiol, vol.53, issue.7, pp.702-706, 2000.

B. Zani, E. D. Pienaar, J. Oliver, and N. Siegfried, Randomized Controlled Trials of HIV/AIDS Prevention and Treatment in Africa: Results from the Cochrane HIV/AIDS Specialized Register

P. Kissinger, O. Plos, T. P. Yamato, C. G. Maher, B. T. Saragiotto et al., How completely are physiotherapy interventions described in reports of randomised trials?, Physiotherapy, vol.6, issue.12, pp.121-126, 2011.

L. Sakzewski, S. Reedman, and T. Hoffmann, Do we really know what they were testing? Incomplete reporting of interventions in randomised trials of upper limb therapies in unilateral cerebral palsy, Research in Developmental Disabilities, vol.59, pp.417-427, 2016.

L. Turner, L. Shamseer, and D. G. Altman, Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals, Cochrane Database Syst Rev, vol.11, p.30, 2012.

S. Hopewell, S. Dutton, L. Yu, C. Altman, and D. G. , The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed, BMJ, vol.340, pp.723-723, 2010.

V. Braun and V. Clarke, What can "thematic analysis" offer health and wellbeing researchers?, International Journal of Qualitative Studies on Health and Well-being, vol.9, issue.1, p.26152, 2014.